Galapagos NV (GLPG.BR) Initiates Nanocort(R) Phase II Clinical Trial For Multiple Sclerosis
11/17/2009 10:55:04 AM
More...
|
Galapagos NV (GLPG.BR) Business Update
11/13/2009 10:35:30 AM
More...
|
Galapagos NV (GLPG.BR) Successfully Completes Placement Of 2,125,925 New Ordinary Shares
10/16/2009 8:40:23 AM
More...
|
Galapagos NV (GLPG.BR) Announces Offering Of New Ordinary Shares
10/15/2009 12:31:59 PM
More...
|
Galapagos NV (GLPG.BR) Wins Expanded Merck & Co., Inc. (MRK) (JOBS) Alliance, Shares Up
10/14/2009 7:32:32 AM
More...
|
Galapagos NV (GLPG.BR) Achieves First Milestone in Anti-infectives Alliance with GlaxoSmithKline (GSK) (JOBS)
10/7/2009 6:33:57 AM
More...
|
Galapagos NV (GLPG.BR) Announces Expanded Drug Discovery Collaboration Between Its Service Division BioFocus DPI And Schering-Plough Research Institute (SGP)
9/24/2009 11:39:39 AM
More...
|
Galapagos NV (GLPG.BR) Collaborates With Charley's Fund, Nash Avery Foundation To Develop SARM Candidate Drug For Duchenne Muscular Dystrophy
9/17/2009 11:37:21 AM
More...
|
Galapagos NV (GLPG.BR) Initiates Second Phase I Clinical Trial For GLPG0259
9/10/2009 11:08:26 AM
More...
|
Galapagos NV (GLPG.BR) Reports Revenue Growth And Improved Net Result In 1H 2009
8/7/2009 10:21:21 AM
More...
|
|